NCT00323206View on ClinicalTrials.gov

Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Malignant Melanoma
Interventions
BIOLOGICAL

IL-12p DNA

Plasmid IL-12 will be administered as an intratympanic (IT) injection.

PROCEDURE

Intratumoral Electroporation

The electroporation apparatus with the electrical contacts will be placed around the tumor site and activated.

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center & Research Institute, Tampa

All Listed Sponsors
collaborator

National Gene Vector Laboratory

OTHER

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT00323206 - Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma | Biotech Hunter | Biotech Hunter